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EDITORIAL
Smoking: the enemy of the heart 
Tabaquismo: el enemigo del corazón
In January of the current year, fifty years of the report of the 
Surgeon General of the United States where for the first time 
the deleterious effects of smoking on health were described, 
have been celebrated1. In the following years an advance 
was made  from identifying an association between smoking 
and cardiovascular disease, to a detailed epidemiological 
and pathophysiological analysis that confirmed a causal 
relationship with coronary artery disease, peripheral artery 
disease, and stroke. 
The two molecules involved directly with cardiovascular 
disease are carbon monoxide and nicotine2. The first 
produces hypoxemia, which promotes the release of free 
radicals and the development of early atherosclerotic 
plaques due to injury and endothelial dysfunction. The 
second affects the cardiovascular system by coronary 
vasoconstriction, release of catecholamines, altered lipid 
metabolism — lower HDL cholesterol and increased LDL 
oxidation-  and induction of a hypercoagulable state by 
alteration of the platelet membrane and an increase of 
thrombin and fibrinogen3. 
For every ten cigarettes daily smoked, mortality from 
cardiovascular disease increases by 18% in men and 31% in 
females. In male smokers acute myocardial infarction may 
appear on average a decade earlier with regard to non-
smokers and if consumption is greater than twenty cigarettes 
per day, it can be anticipated just about twenty years. 
Nonsmoking women developed a first coronary event nearly 
ten years later than men; however, smokers may develop an 
acute myocardial infarction at similar ages than men4,5. 
Today smoking  is recognized as the pandemic of the XXI 
century, a chronic and addictive disease  that kills 50% of 
consumers. It is responsible for over 5 million deaths each 
year worldwide —1 million in America— and it will double by 
2025, without counting the costs of managing patients with 
tobacco-related diseases, which are astronomical6. 
In Colombia, according to data obtained from the study 
conducted last year by the Institute for Health Technology 
Assessment (IETS), along with the National Cancer Institute, 
each year 112,891 people suffer heart disease and each 
day 72 die from diseases attributed to tobacco. 4.23 billion 
Colombian pesos are spent in health care costs each year for 
diseases caused by the consumption of tobacco7. 
The response of society to this public health problem is 
the first international treaty on health: The World Health 
Organization (WHO) Framework Convention on Tobacco Control 
(FCTC), which aims to “protect present and future generations 
from the devastating health, social, environmental and 
economic consequences of tobacco consumption and  exposure 
to tobacco smoke.” It was formalized on May 21, 2003 and to 
date has been signed by 168 countries. It is a treaty of public 
policies that include among others, rising tobacco prices and 
taxes to reduce its demand, 100% smokefree spaces, ban 
on advertising, promotion and sponsorship of tobacco and 
education, communication, training and public awareness8. 
Colombia ratified its accession to this treaty in 2008 and in 
2009 enacted the 1335 law to guarantee the protection of 
non-smokers, especially children, and to establish rules on 
the use, sale, advertising and promotion of cigarettes an 
tobacco products. The creation of health and educational 
programs to reduce consumption and encourage the cessation 
of tobacco dependence was also established. Nevertheless, 
it is unfortunate that the regulation and implementation of 
this law advances with astonishing slowness in topics such as 
taxes, rates, and penalties9. 
So, it is urgent that we, the doctors who daily see the 
consequences of the tobacco consumption, take a clear and 
defined position on the leading preventable cause of death 
and disease in the world on several fronts. First, diagnose, 
record in the clinical history and provide systematic support 
for smokers. Promote the creation of specific lectures on 
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tobacco smoking in pre and postgraduate universities of 
Medicine, Dentistry, Nursing and others to popularize the 
management of this disease, as it has been achieved with 
many cardiovascular and pulmonary diseases. Promote the 
creation of specialized consultations and cessation clinics 
structured to provide effective treatment to tobacco 
addicts. Require the State to implement current regulations 
such as strengthening the smokefree spaces, increase the 
warnings on packets above 50%, raise tobacco prices and 
taxes and effectively prohibit the retail sale to minors, 
and finally, participate from the scientific associations to 
achieve the inclusion of medicines needed to treat these 
patients in mandatory health plans. 
Great challenges are ahead. The most important one is 
to move towards greater social awareness for compliance 
with the laws on the consumption of tobacco and the 
need to address smoking as a priority in our work plans. 
It is necessary to promote and support tobacco prevention 
programs in schools, universities and communities seeking 
to combat the increase of young smokers. 
Finally, it is convenient promote training and research 
from the academy to obtain health professionals suited to 
the management of patients suffering from this disease. 
It behooves us to write the history of the next fifty years 
of the fight against smoking. 
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